Home > News > Aging and Nanotechnology
September 16th, 2004
Aging and Nanotechnology
Mike Treder: This morning I went to a TV studio in Washington D.C. where I participated in the taping of a one-hour SAGE Crossroads program on the possibilities of using nanotechnology to combat disease and aging.
The main point I tried to make today is that unless policy questions concerning the potentially disruptive societal implications of nanotechnology -- political, economic, military, humanitarian, and environmental -- are decided well in advance, progress toward the implementation of anti-aging therapies might be delayed or halted. Disputes over such critical areas of interest could dwarf current controversies about biotechnology and genetic engineering.
PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014
PETA science consortium experts to present at international nanotechology workshop: PETA International Science Consortium, Ltd., Is a Sponsor of Nano Risk Analysis II September 12th, 2014
PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014
Scientists disagree on responsible research April 8th, 2014
Patent for the Novel Cancer Therapies – Ceramide Nanoliposomes March 4th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015
Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015